Literature DB >> 9078237

Activation of CPP32 and Mch3 alpha in wild-type p53-induced apoptosis.

J M Chandler1, E S Alnemri, G M Cohen, M MacFarlane.   

Abstract

DNA-damaging agents induce apoptosis primarily by a p53-dependent pathway. LTR6 cells containing a temperature-sensitive p53 were used to dissect further the mechanisms of p53-induced apoptosis. Apoptosis was accompanied by the processing and activation of CPP32 and Mch3 alpha, together with the cleavage of poly(ADP-ribose) polymerase and lamin B1. These results demonstrate a critical role for the activation of interleukin-1 beta-converting enzyme-like proteases in p53-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9078237      PMCID: PMC1218152          DOI: 10.1042/bj3220019

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  A flow-cytometric method for the separation and quantitation of normal and apoptotic thymocytes.

Authors:  X M Sun; R T Snowden; D N Skilleter; D Dinsdale; M G Ormerod; G M Cohen
Journal:  Anal Biochem       Date:  1992-08-01       Impact factor: 3.365

Review 2.  Apoptosis: mechanisms and roles in pathology.

Authors:  M J Arends; A H Wyllie
Journal:  Int Rev Exp Pathol       Date:  1991

3.  Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.

Authors:  D Michalovitz; O Halevy; M Oren
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

4.  p53-mediated cell death: relationship to cell cycle control.

Authors:  E Yonish-Rouach; D Grunwald; S Wilder; A Kimchi; E May; J J Lawrence; P May; M Oren
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

5.  Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells.

Authors:  J J Ryan; R Danish; C A Gottlieb; M F Clarke
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

6.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

7.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

8.  Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6.

Authors:  E Yonish-Rouach; D Resnitzky; J Lotem; L Sachs; A Kimchi; M Oren
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

9.  Ca(2+)-regulated serine protease associated with the nuclear scaffold.

Authors:  G A Clawson; L L Norbeck; C L Hatem; C Rhodes; P Amiri; J H McKerrow; S R Patierno; G Fiskum
Journal:  Cell Growth Differ       Date:  1992-11

10.  Identification and characterization of ICH-2, a novel member of the interleukin-1 beta-converting enzyme family of cysteine proteases.

Authors:  J Kamens; M Paskind; M Hugunin; R V Talanian; H Allen; D Banach; N Bump; M Hackett; C G Johnston; P Li
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

View more
  4 in total

1.  Activation of caspases and p53 by bovine herpesvirus 1 infection results in programmed cell death and efficient virus release.

Authors:  L R Devireddy; C J Jones
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Nuclear lamins and progerin are dispensable for antioxidant Nrf2 response to arsenic and cadmium.

Authors:  Kazunori Hashimoto; Rima Majumdar; Yoshiaki Tsuji
Journal:  Cell Signal       Date:  2017-02-14       Impact factor: 4.315

Review 3.  Caspases: the executioners of apoptosis.

Authors:  G M Cohen
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

Review 4.  Apoptosis by p53: mechanisms, regulation, and clinical implications.

Authors:  R V Sionov; Y Haupt
Journal:  Springer Semin Immunopathol       Date:  1998
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.